IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:1410-1415.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.06-0890

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, C.-J.
Right arrow Articles by Hare, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, C.-J.
Right arrow Articles by Hare, W. A.

{alpha}2 Adrenergic Receptor–Mediated Modulation of Cytosolic Ca++ Signals at the Inner Plexiform Layer of the Rat Retina

Cun-Jian Dong, Yuanxing Guo, Larry Wheeler, and William A. Hare

From the Department of Biological Sciences, Allergan Pharmaceuticals, Inc., Irvine, California.

PURPOSE. Compelling evidence suggests that {alpha}2 agonists, such as brimonidine, protect retinal ganglion cells (RGCs) from injury in a wide range of animal models. However, the mechanism of action for this protection and the physiological role of the {alpha}2 adrenergic system in the retina is not well understood. A major goal of this work was to explore the role of the {alpha}2 adrenergic system in the modulation of cytosolic Ca2+ signaling at retinal synaptic layers, particularly the inner plexiform layer (IPL), where communication between RGCs and their presynaptic cells takes place.

METHODS. Functional Ca2+ imaging at the inner plexiform layer (IPL) and outer plexiform layer (OPL) of living rat retinal slices was conducted with a high-speed confocal system. The relative changes of cytosolic free Ca2+ were monitored with the fluorescent Ca2+ dye fluo-4. The Ca2+ signal was elicited by membrane depolarization produced by a high K+ (40 mM) Ringer solution that was delivered rapidly and briefly to the test regions of the retinal slice by a custom-made multichannel local perfusion system.

RESULTS. A brief application (8 seconds) of high K+ Ringer elicited a robust cytosolic Ca2+ increase at the IPL and OPL. In both cases, this Ca2+ signal was eliminated by nimodipine, a selective L-type voltage-gated Ca2+-channel blocker, or when the extracellular Ca2+ in the Ringer was replaced with equal molar EGTA. At IPL, the Ca2+ signal was also suppressed in a dose-dependent manner by brimonidine and other {alpha}2 receptor agonists, such as medetomidine. The suppressive action of brimonidine and medetomidine was completely blocked by classic {alpha}2 receptor antagonists, such as yohimbine, rauwolscine, and atipamezole. Interestingly, the {alpha}2 receptor agonists had no effect on the high K+ Ringer-elicited cytosolic Ca2+ signal at OPL. Blocking the N-methyl-D-aspartate (NMDA) type of ionotropic glutamate receptor with D-AP5 attenuated this high K+–elicited Ca2+ signal by approximately 20% at IPL. D-AP5 had no effect on the Ca2+ signal at OPL.

CONCLUSIONS. These findings provide the first direct evidence of {alpha}2 receptor–mediated modulation of L-type Ca2+ channel activity in the CNS (the retina is part of the CNS). This {alpha}2 modulation appears to occur at the IPL but not at the OPL of the retina. These findings suggest that a physiological function of the retinal {alpha}2 system is the regulation of synaptic transmission at IPL and that brimonidine and other {alpha}2 agonists may protect RGCs under disease conditions by preventing abnormal elevation of cytosolic free Ca2+ either in RGCs, in their presynaptic cells, or in both.





This article has been cited by other articles:


Home page
IOVSHome page
C.-J. Dong, Y. Guo, P. Agey, L. Wheeler, and W. A. Hare
{alpha}2 Adrenergic Modulation of NMDA Receptor Function as a Major Mechanism of RGC Protection in Experimental Glaucoma and Retinal Excitotoxicity
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4515 - 4522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology